Feasibility of Parasacral Transcutaneous Electrical Nerve Stimulation PTENS for Voiding Dysfunction in Peds Population
Feasibility of Home Parasacral Transcutaneous Electrical Nerve Stimulation (PTENS) for the Voiding Dysfunction in the Pediatric Population: A Pilot Study
1 other identifier
interventional
30
1 country
1
Brief Summary
Pilot study for determining feasibility of home parasacral transcutaneous electrical nerve stimulation in treatment of urinary urgency and incontinence.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2019
CompletedFirst Submitted
Initial submission to the registry
April 19, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2020
CompletedFirst Posted
Study publicly available on registry
September 30, 2020
CompletedResults Posted
Study results publicly available
March 8, 2022
CompletedMarch 17, 2022
March 1, 2022
1.2 years
April 19, 2019
January 5, 2022
March 8, 2022
Conditions
Outcome Measures
Primary Outcomes (2)
Dysfunctional Voiding Symptom Score
At week 6 a Dysfunctional Voiding Scoring System Score. Descriptive statistics will be used to analyze these data in comparison to pre-study scores. As stated above, Dysfunctional Voiding Symptom Score is a validated clinical questionnaire designed to quantify the severity of pediatric voiding dysfunction on a scale of 0 (non-existent) to 30 (most severe).
week 6
Voiding Diary and the Number of Episodes of Incontinence Per Day
48-hour Voiding Diary and Nighttime Wetting log will be repeated and evaluated. This was added as a separate primary outcome as it is separate from the Dysfunctional Voiding Symptom Score. The voiding diary will be used to evaluate the number of episodes of incontinence per day and descriptive statistics will be used to compare this to pre-study numbers.
week 6, week 12
Secondary Outcomes (1)
Secondary Outcome. Review of Adverse Events.
Week 6 through Week 12
Study Arms (2)
Standard Urotherapy
ACTIVE COMPARATORPatients who meet eligibility criteria who will be counselled on standard recommendations for bladder management.
Standard Urotherapy + PTENS
EXPERIMENTALPatients who meet eligibility criteria who will be counselled on standard recommendations for bladder management AND use parasacral percutaneous TENS as additional treatment.
Interventions
electrode patches placed on skin of lower back just above each side of the gluteal cleft (parasacral) and attached to TENS unit at specific settings three times a week for 30 minutes for 12 weeks.
standard behavioral therapy recommendations including timed voiding, fluid intake recommendations and bowel management recommendations including videos instructing patients and parents on these issues. This is current standard of care.
Eligibility Criteria
You may qualify if:
- Toilet trained (age 6) to age 17
- Diagnosis of urinary dysfunction, voiding dysfunction, overactive bladder, urgency incontinence, nocturnal enuresis. (These patients may also have an element of bowel dysfunction; however, we will not include a patient who had ONLY bowel dysfunction and NOT a voiding dysfunction).
You may not qualify if:
- Known neurologic diagnosis - such as myelomeningocele, caudal regression
- Known seizure disorder
- Age \< 6 or \> 17
- Lack of follow-up within 6 months of treatment
- Pacemaker, vagal nerve stimulator, or other implanted electrical device
- Intolerance of electrical nerve stimulation
- Pregnancy
- Implanted metal hardware
- Open sores or wounds over the sacral area
- Currently catheterizing for bladder drainage
- Known anatomic lower urinary tract abnormality (may be congenital or iatrogenic)
- Bowel only voiding dysfunction (Constipation ICD-10 K59.00)
- Non-English speaking families
- Families with health literacy precluding completion of questionnaires and voiding diaries
- Concurrent use of anticholinergics, alpha blockers or beta agonists for urologic treatments
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Utah/Primary Children's Pediatric Urology
Salt Lake City, Utah, 84112, United States
Related Publications (2)
de Paula LIDS, de Oliveira LF, Cruz BP, de Oliveira DM, Miranda LM, de Moraes Ribeiro M, Duque RO, de Figueiredo AA, de Bessa J Jr, Netto JMB. Parasacral transcutaneous electrical neural stimulation (PTENS) once a week for the treatment of overactive bladder in children: A randomized controlled trial. J Pediatr Urol. 2017 Jun;13(3):263.e1-263.e6. doi: 10.1016/j.jpurol.2016.11.019. Epub 2016 Dec 21.
PMID: 28089606BACKGROUNDFarhat W, Bagli DJ, Capolicchio G, O'Reilly S, Merguerian PA, Khoury A, McLorie GA. The dysfunctional voiding scoring system: quantitative standardization of dysfunctional voiding symptoms in children. J Urol. 2000 Sep;164(3 Pt 2):1011-5. doi: 10.1097/00005392-200009020-00023.
PMID: 10958730BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
Limitations included patients being lost to follow-up or not completing their voiding diaries or DVSS questionnaires so that the number of patients with complete information was only slightly higher than half of the total who were initially enrolled.
Results Point of Contact
- Title
- Glen Lau, MD
- Organization
- University of Utah School of Medicine
Study Officials
- PRINCIPAL INVESTIGATOR
Glen A Lau, MD
University of Utah
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- patients will be randomized to standard urotherapy or urotherapy + PTENS
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Surgery
Study Record Dates
First Submitted
April 19, 2019
First Posted
September 30, 2020
Study Start
April 1, 2019
Primary Completion
June 1, 2020
Study Completion
July 1, 2020
Last Updated
March 17, 2022
Results First Posted
March 8, 2022
Record last verified: 2022-03
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will be stored on password protected computers in the facility and collected data will be entered in a REDCap database. Individual participant data will not be shared with any individuals other than the study personnel as only these individuals will have access to the data.